🇺🇸 FDA
Patent

US 9987326

Klotho protein and related compounds for the treatment and diagnosis of cancer

granted A61KA61K38/1709A61P

Quick answer

US patent 9987326 (Klotho protein and related compounds for the treatment and diagnosis of cancer) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/1709, A61P, A61P35/00